In previous studies, these compounds showed anti-obesity properties that could be explained by different mechanisms, such as modulating neuro-hormones that play a role in satiety, like neuropeptide Y, supressing lipogenesis, or even modifying the microbiota. Here, NPY is linked to obesity due to melanocortin 4 receptor deficiency.